437 related articles for article (PubMed ID: 29263297)
1. Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung.
Sava P; Ramanathan A; Dobronyi A; Peng X; Sun H; Ledesma-Mendoza A; Herzog EL; Gonzalez AL
JCI Insight; 2017 Dec; 2(24):. PubMed ID: 29263297
[TBL] [Abstract][Full Text] [Related]
2. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
[TBL] [Abstract][Full Text] [Related]
4. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
[TBL] [Abstract][Full Text] [Related]
5. Matrix abnormalities in pulmonary fibrosis.
Upagupta C; Shimbori C; Alsilmi R; Kolb M
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29950306
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast-matrix interplay: Nintedanib and pirfenidone modulate the effect of IPF fibroblast-conditioned matrix on normal fibroblast phenotype.
Epstein Shochet G; Wollin L; Shitrit D
Respirology; 2018 Aug; 23(8):756-763. PubMed ID: 29532550
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Matrix Stiffness and ß-Catenin Signaling in Endothelial-to-Mesenchymal Transition of Aortic Valve Endothelial Cells.
Zhong A; Mirzaei Z; Simmons CA
Cardiovasc Eng Technol; 2018 Jun; 9(2):158-167. PubMed ID: 29761409
[TBL] [Abstract][Full Text] [Related]
8. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
Cho N; Razipour SE; McCain ML
Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor GATA-6 is expressed in quiescent myofibroblasts in idiopathic pulmonary fibrosis.
Leppäranta O; Pulkkinen V; Koli K; Vähätalo R; Salmenkivi K; Kinnula VL; Heikinheimo M; Myllärniemi M
Am J Respir Cell Mol Biol; 2010 May; 42(5):626-32. PubMed ID: 19597127
[TBL] [Abstract][Full Text] [Related]
10. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.
Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA
Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297
[TBL] [Abstract][Full Text] [Related]
11. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
12. Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.
Giménez A; Duch P; Puig M; Gabasa M; Xaubet A; Alcaraz J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29144435
[TBL] [Abstract][Full Text] [Related]
13. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
14. MeCP2 epigenetically regulates alpha-smooth muscle actin in human lung fibroblasts.
Xiang Z; Zhou Q; Hu M; Sanders YY
J Cell Biochem; 2020 Jul; 121(7):3616-3625. PubMed ID: 32115750
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2: a novel therapeutic target for idiopathic pulmonary fibrosis using selective small molecule inhibitors.
Fell S; Wang Z; Blanchard A; Nanthakumar C; Griffin M
Amino Acids; 2021 Feb; 53(2):205-217. PubMed ID: 33474654
[TBL] [Abstract][Full Text] [Related]
16. LTBP2 is secreted from lung myofibroblasts and is a potential biomarker for idiopathic pulmonary fibrosis.
Enomoto Y; Matsushima S; Shibata K; Aoshima Y; Yagi H; Meguro S; Kawasaki H; Kosugi I; Fujisawa T; Enomoto N; Inui N; Nakamura Y; Suda T; Iwashita T
Clin Sci (Lond); 2018 Jul; 132(14):1565-1580. PubMed ID: 30006483
[TBL] [Abstract][Full Text] [Related]
17. Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1.
Estany S; Vicens-Zygmunt V; Llatjós R; Montes A; Penín R; Escobar I; Xaubet A; Santos S; Manresa F; Dorca J; Molina-Molina M
BMC Pulm Med; 2014 Jul; 14():120. PubMed ID: 25064447
[TBL] [Abstract][Full Text] [Related]
18. Novel Mechanisms for the Antifibrotic Action of Nintedanib.
Rangarajan S; Kurundkar A; Kurundkar D; Bernard K; Sanders YY; Ding Q; Antony VB; Zhang J; Zmijewski J; Thannickal VJ
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):51-9. PubMed ID: 26072676
[TBL] [Abstract][Full Text] [Related]
19. Lipoxin A4 Attenuates Constitutive and TGF-β1-Dependent Profibrotic Activity in Human Lung Myofibroblasts.
Roach KM; Feghali-Bostwick CA; Amrani Y; Bradding P
J Immunol; 2015 Sep; 195(6):2852-60. PubMed ID: 26276873
[TBL] [Abstract][Full Text] [Related]
20. Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.
Bocchino M; Agnese S; Fagone E; Svegliati S; Grieco D; Vancheri C; Gabrielli A; Sanduzzi A; Avvedimento EV
PLoS One; 2010 Nov; 5(11):e14003. PubMed ID: 21103368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
